Intranasal insulin had a positive effect on cognition and gait. The intranasal insulin treated T2DM patients walked faster, had increased cerebral blood flow, and decreased plasma insulin, while the control group had improved executive function and verbal memory. This evidence concerns the gene INS and type 2 diabetes mellitus.